Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

about

Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis

P2860

Q58751678-18226680-6A71-472B-9ABE-BABE36E8C46F

P2860

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

Item

http://www.wikidata.org/entity/Q52671034

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

@en

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

@nl

type

Item

label

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

@en

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

@nl

prefLabel

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

@en

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

@nl

P1476

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

@en

P2093

Anders Sundström

http://www.w3.org/2001/XMLSchema#string

Anna Borgenvik

http://www.w3.org/2001/XMLSchema#string

Camilla U Persson

http://www.w3.org/2001/XMLSchema#string

Holger Weishaupt

http://www.w3.org/2001/XMLSchema#string

James E Bradner

http://www.w3.org/2001/XMLSchema#string

Jun Qi

http://www.w3.org/2001/XMLSchema#string

Sara Bolin

http://www.w3.org/2001/XMLSchema#string

William A Weiss

http://www.w3.org/2001/XMLSchema#string

Yoon-Jae Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Selective inhibition of BET bromodomains

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease

Molecular subgroups of medulloblastoma: the current consensus

Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks

Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitor

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

BET domain co-regulators in obesity, inflammation and cancer

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma

Subtypes of medulloblastoma have distinct developmental origins

P2888

s41388-018-0135-1

P304

2850-2862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41388-018-0135-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fredrik J Swartling

P577

2018-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29511348

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma

P932

5966365

http://www.w3.org/2001/XMLSchema#string

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

about

P2860

P2860

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932